Home/Filings/4/0001209191-22-040616
4//SEC Filing

Hayes Christopher G. 4

Accession 0001209191-22-040616

CIK 0001660334other

Filed

Jul 4, 8:00 PM ET

Accepted

Jul 5, 4:13 PM ET

Size

4.6 KB

Accession

0001209191-22-040616

Insider Transaction Report

Form 4
Period: 2022-07-05
Hayes Christopher G.
CHIEF LEGAL OFFICER
Transactions
  • Purchase

    Common Stock

    2022-07-05$2.10/sh+5,714$11,9998,214 total

Issuer

Verrica Pharmaceuticals Inc.

CIK 0001660334

Entity typeother

Related Parties

1
  • filerCIK 0001805359

Filing Metadata

Form type
4
Filed
Jul 4, 8:00 PM ET
Accepted
Jul 5, 4:13 PM ET
Size
4.6 KB